Pharmacokinetics and Safety of Indinavir in Human Immunodeficiency Virus-Infected Pregnant Women
Jashvant D. Unadkat(University of Washington), Ruth Tuomala(Brigham and Women's Hospital), Paul Deutsch, Sharon Huang(FuelCell Energy (United States)), Elizabeth Smith(National Jewish Health), Anita Mathias(Gilead Sciences (United States)), D. Heather Watts(National Institutes of Health), Kathleen A. Kaiser(Frontier Science & Technology Research Foundation), Lynne Mofenson(Elizabeth Glaser Pediatric AIDS Foundation), Michael D. Hughes(Virginia Tech), Diane W. Wara(University of California, San Francisco), Diane T. Holland(University of California San Diego), James D. Connor, Bach-Yen Nguyen(Merck & Co., Inc., Rahway, NJ, USA (United States)), Mary E. Paul(Texas Children's Hospital)
Cited by 84
Related Papers
Treatment with Indinavir, Zidovudine, and Lamivudine in Adults with Human Immunodeficiency Virus Infection and Prior Antiretroviral Therapy
|New England Journal of Medicine|1997|1.9k
Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial
|The Lancet|1999|1.7k
Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline
|Journal of Clinical Oncology|2014|1.2k
Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: ASCO Guideline Update
|Journal of Clinical Oncology|2020|1.1k